EU Assesses Regeneron/Roche COVID-19 Antibody Cocktail for Authorization EU Assesses Regeneron/Roche COVID-19 Antibody Cocktail for Authorization

The EU ' s drug regulator said it was evaluating a marketing authorization for an antibody cocktail developed by Roche and Regeneron for treatment and prevention of COVID-19 in people above the age of 12.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news